{"id":"W2131882149","doi":"10.1001/jama.295.19.2275","title":"Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies","year":2006,"lang":"en","type":"review","venue":"JAMA","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2476,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Medicine; Internal medicine; Adalimumab; Rheumatoid arthritis; Rheumatism; Infliximab; Etanercept; Placebo; Abatacept; Randomized controlled trial; Odds ratio; Rheumatology; Cochrane Library; Meta-analysis; Physical therapy; Immunology; Tumor necrosis factor alpha; Alternative medicine; Pathology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0142216508254416,"score_gpt":0.3024879922890191,"score_spread":0.2882663414635775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}